Drugs / LY3079514
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02242903 | Oct 2014 → Jun 2015 | — | Eli Lilly and Company | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LY3079514 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02242903 ↗ |
| Route | Subcutaneous | “Administered SC” NCT02242903 ↗ |